{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:33:25Z","timestamp":1793414005803,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.gim.2022.01.017","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T17:16:33Z","timestamp":1645809393000},"page":"1017-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-1672","authenticated-orcid":false,"given":"Gregory F.","family":"Guzauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Garbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh F.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.gim.2022.01.017_bib1","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of screening for Lynch syndrome among patients with colorectal cancer","volume":"26","author":"Hampel","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.gim.2022.01.017_bib2","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2012.13088","article-title":"Identification of Lynch syndrome among patients with colorectal cancer","volume":"308","author":"Moreira","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gim.2022.01.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin Genet"},{"issue":"22","key":"10.1016\/j.gim.2022.01.017_bib4","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gim.2022.01.017_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.mayocp.2013.09.006","article-title":"The increasing incidence of young-onset colorectal cancer: a call to action","volume":"89","author":"Ahnen","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.gim.2022.01.017_bib6","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1055-9965.EPI-08-0301","article-title":"Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States","volume":"17","author":"Kastrinos","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.gim.2022.01.017_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10689-009-9290-4","article-title":"Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis","volume":"9","author":"Jasperson","year":"2010","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.gim.2022.01.017_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/JCO.2014.57.8088","article-title":"Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk","volume":"33","author":"ten Broeke","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.gim.2022.01.017_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.gim.2022.01.017_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","volume":"66","author":"M\u00f8ller","year":"2017","journal-title":"Gut"},{"issue":"19","key":"10.1016\/j.gim.2022.01.017_bib11","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gim.2022.01.017_bib12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer","volume":"147","author":"Giardiello","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gim.2022.01.017_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.gim.2022.01.017_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.6004\/jnccn.2016.0108","article-title":"Genetic\/familial high-risk assessment: colorectal version 1.2016, nccn clinical practice guidelines in oncology","volume":"14","author":"Provenzale","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.gim.2022.01.017_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cgh.2013.04.044","article-title":"Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review","volume":"11","author":"Sharaf","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gim.2022.01.017_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10620-015-3964-6","article-title":"Universal screening of colorectal cancers for Lynch syndrome: challenges and opportunities","volume":"61","author":"Vindigni","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.gim.2022.01.017_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","article-title":"EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"issue":"19","key":"10.1016\/j.gim.2022.01.017_bib19","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2016.69.6120","article-title":"Development and validation of the PREMM5 model for comprehensive risk assessment of Lynch syndrome","volume":"35","author":"Kastrinos","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.gim.2022.01.017_bib20","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2016.5989","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement","volume":"315","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.gim.2022.01.017_bib21","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41436-020-0876-4","article-title":"Clinical outcomes of a genomic screening program for actionable genetic conditions","volume":"22","author":"Buchanan","year":"2020","journal-title":"Genet Med"},{"issue":"51","key":"10.1016\/j.gim.2022.01.017_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21510","article-title":"Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation","volume":"21","author":"Snowsill","year":"2017","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1016\/j.gim.2022.01.017_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","article-title":"Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer","volume":"118","author":"J\u00e4rvinen","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gim.2022.01.017_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10689-009-9281-5","article-title":"Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation","volume":"8","author":"Stupart","year":"2009","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.gim.2022.01.017_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/0272989X14536779","article-title":"A review and meta-analysis of colorectal cancer utilities","volume":"34","author":"Djalalov","year":"2014","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.gim.2022.01.017_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1940-6207.CAPR-10-0262","article-title":"Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population","volume":"4","author":"Dinh","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.gim.2022.01.017_bib30","series-title":"In: Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer","article-title":"AHRQ Technology Assessments","author":"Zauber","year":"2007"},{"issue":"5","key":"10.1016\/j.gim.2022.01.017_bib31","first-page":"e179","article-title":"Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome","volume":"18","author":"Wang","year":"2012","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.gim.2022.01.017_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/gim.2015.53","article-title":"The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates","volume":"17","author":"Grosse","year":"2015","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.gim.2022.01.017_bib33","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41436-019-0457-6","article-title":"Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis","volume":"21","author":"Zhang","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2022.01.017_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13053-017-0078-5","article-title":"Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report","volume":"15","author":"Sepp\u00e4l\u00e4","year":"2017","journal-title":"Hered Cancer Clin Pract"},{"issue":"5","key":"10.1016\/j.gim.2022.01.017_bib35","doi-asserted-by":"crossref","first-page":"djv382","DOI":"10.1093\/jnci\/djv382","article-title":"Annual medical expenditure and productivity loss among colorectal, female breast, and prostate cancer survivors in the United States","volume":"108","author":"Zheng","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.gim.2022.01.017_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/gim.2014.190","article-title":"Economic evaluation of genetic screening for Lynch syndrome in Germany","volume":"17","author":"Severin","year":"2015","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.gim.2022.01.017_bib37","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41436-019-0580-4","article-title":"Cost-effectiveness of population genomic screening","volume":"21","author":"Veenstra","year":"2019","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.gim.2022.01.017_bib38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.gim.2022.01.017_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22874","article-title":"Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States","volume":"3","author":"Guzauskas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.gim.2022.01.017_bib40","first-page":"105","article-title":"Longitudinal adherence to colorectal cancer screening guidelines","volume":"22","author":"Cyhaniuk","year":"2016","journal-title":"Am J Manag Care"},{"issue":"23","key":"10.1016\/j.gim.2022.01.017_bib41","doi-asserted-by":"crossref","first-page":"34546","DOI":"10.18632\/oncotarget.8945","article-title":"A\u00a0meta-analysis of MSI frequency and race in colorectal cancer","volume":"7","author":"Ashktorab","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.gim.2022.01.017_bib42","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cgh.2016.03.037","article-title":"Colorectal tumors from different racial and ethnic minorities have similar rates of mismatch repair deficiency","volume":"14","author":"Berera","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gim.2022.01.017_bib43","doi-asserted-by":"crossref","first-page":"dju075","DOI":"10.1093\/jnci\/dju075","article-title":"Colorectal cancer control: providing adequate care to those who need it","volume":"106","author":"Brawley","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"Suppl 1","key":"10.1016\/j.gim.2022.01.017_bib44","first-page":"S32","article-title":"Health disparities in colorectal cancer among racial and ethnic minorities in the United States","volume":"7","author":"Jackson","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"12","key":"10.1016\/j.gim.2022.01.017_bib45","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.cgh.2018.08.038","article-title":"Low referral rate for genetic testing in racially and ethnically diverse patients despite universal colorectal cancer screening","volume":"16","author":"Muller","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gim.2022.01.017_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X15583266","article-title":"Distributional cost-effectiveness analysis: a tutorial","volume":"36","author":"Asaria","year":"2016","journal-title":"Med Decis Making"},{"issue":"6","key":"10.1016\/j.gim.2022.01.017_bib47","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hec.3058","article-title":"Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme","volume":"24","author":"Asaria","year":"2015","journal-title":"Health Econ"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:52:17Z","timestamp":1761097937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360022000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1098360022000338"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2022.01.017","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2022.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}